A new era of cell therapy has well and truly arrived with the iPSC field setting a trailblazing fire with its potential to develop fully scalable, off-the-shelf cell lines reducing the cost of ...

Century Therapeutics, Inc. (IPSC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...

It also partnered with Panasonic for automated iPSC cell manufacturing. With this new automated iPSC technology and its strong partnerships with Taiwanese CDMO companies, LumiSTAR is now able to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

研究人员开展研究时用到了几个主要关键技术方法。首先是利用 Ficoll-Paque 方法从人外周血中分离外周血单核细胞（PBMCs），再用 CytoTune-iPSC 2.1 Sendai 重编程试剂盒将其重编程为 iPSCs。然后，使用 StemMACS? CardioDiff Kit XF 将 iPSCs 分化为 iCMs。最后，运用 RNA 开关技术 ...

KZR Kezar Life Sciences, Inc.

The approval of XellSmart’s clinical trial, along with the special exemption granted, signifies the FDA’s recognition of XellSmart’s well-established clinical-grade iPSC-derived cell drug development, ...

Collaboration to Advance First-in-Human Clinical Study Using Autologous iPSC Technology Cellino, a biotechnology company pioneering autonomous biomanufacturing for personalized regenerative ...

干性年龄相关性黄斑变性（AMD）治疗手段有限，研究人员开展 iPSC-RPE 细胞悬液相关研究。通过改进制备工艺，证明其临床前安全性和有效性，获印度 IND 批准，为干性 AMD 治疗带来新希望。 在人口老龄化加剧的当下，眼部疾病逐渐成为影响人们生活质量的重要 ...

The partners aim to industrialize what they claim will be the first clinical-stage autologous induced pluripotent stem cell-derived (iPSC) therapy for peripheral artery disease and coronary artery ...